Concord Medical Services Holdings
Market Cap
US$102.2m
Last Updated
2019/10/18 00:01 UTC
Data Sources
Company Financials +
Executive Summary
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.
Snowflake
Fundamentals
Concerning outlook with worrying balance sheet.
Similar Companies
Share Price & News
How has Concord Medical Services Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
2.4%
CCM
5.8%
US Healthcare
1.8%
US Market
1 Year Return
-17.9%
CCM
-6.5%
US Healthcare
7.3%
US Market
Return vs Industry: CCM underperformed the US Healthcare industry which returned -6.5% over the past year.
Return vs Market: CCM underperformed the US Market which returned 7.3% over the past year.
Shareholder returns
| CCM | Industry | Market | |
|---|---|---|---|
| 7 Day | 2.4% | 5.8% | 1.8% |
| 30 Day | -5.4% | 2.5% | -0.7% |
| 90 Day | -13.1% | -1.8% | 0.06% |
| 1 Year | -17.9%-17.9% | -5.0%-6.5% | 9.7%7.3% |
| 3 Year | -46.1%-46.1% | 33.9%28.6% | 46.3%36.9% |
| 5 Year | -61.2%-68.1% | 65.6%55.8% | 64.5%46.5% |
Price Volatility Vs. Market
How volatile is Concord Medical Services Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 weeks ago | Simply Wall St
Introducing Concord Medical Services Holdings (NYSE:CCM), The Stock That Slid 66% In The Last Five Years2 months ago | Simply Wall St
Do Directors Own Concord Medical Services Holdings Limited (NYSE:CCM) Shares?3 months ago | Simply Wall St
Concord Medical Services Holdings Limited (NYSE:CCM): Is Breakeven Near?Valuation
Is Concord Medical Services Holdings undervalued compared to its fair value and its price relative to the market?
3.94x
Price to Book (PB) ratio
Share Price vs. Fair Value
Undervalued: Insufficient data to calculate CCM's fair value to establish if it is undervalued.
Significantly Undervalued: Insufficient data to calculate CCM's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: CCM is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.
PE vs Market: CCM is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
Low PEG Ratio: Insufficient data to calculate CCM's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CCM is overvalued based on its PB Ratio (3.9x) compared to the US Healthcare industry average (2.5x).
Next Steps
Future Growth
How is Concord Medical Services Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
118.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CCM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CCM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CCM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CCM's revenue (10.2% per year) is forecast to grow faster than the US market (7.3% per year).
High Growth Revenue: CCM's revenue (10.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: CCM's Return on Equity is forecast to be low in 3 years time (0.3%).
Next Steps
Past Performance
How has Concord Medical Services Holdings performed over the past 5 years?
-48.8%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: CCM is unprofitable, and losses have increased over the past 5 years at a rate of -48.8% per year.
Accelerating Growth: Unable to compare CCM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CCM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (5.3%).
Return on Equity
High ROE: CCM has a negative Return on Equity (-11.38%), as it is currently unprofitable.
Return on Assets
ROA vs Industry: CCM is currently unprofitable, so its Return on Assets is negative.
Return on Capital Employed
ROCE Improving: CCM is currently unprofitable, so its Return on Capital Employed is negative.
Next Steps
Financial Health
How is Concord Medical Services Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: CCM's short term assets (CN¥816.4M) exceeds its short term liabilities (CN¥498.1M)
Long Term Liabilities: CCM's short term assets (816.4M) do not cover its long term liabilities (1.5B)
Debt to Equity History and Analysis
Debt Level: CCM's debt to equity ratio (51%) is considered high
Reducing Debt: CCM's debt to equity ratio has increased from 44.9% to 51% over the past 5 years.
Balance Sheet
Inventory Level: CCM has a high level of physical assets or inventory.
Debt Coverage by Assets: CCM's debt is not covered by short term assets (assets are 0.6x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if CCM has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CCM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Next Steps
Dividend
What is Concord Medical Services Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate CCM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate CCM's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if CCM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CCM's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: CCM is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CCM's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of Concord Medical Services Holdings's salary, the management and board of directors tenure and is there insider trading?
0.6yrs
Average management tenure
CEO
Jianyu Yang (48yo)
11.8yrs
Tenure
Dr. Jianyu Yang has been the Chief Executive Officer at Concord Medical Services Holdings Limited since 2008 and served as its President from 2008 to November 27, 2011. Dr. Yang served as the Chief Executi ...
Management Age and Tenure
0.6yrs
Average Tenure
50.5yo
Average Age
Experienced Management: CCM's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.
Board Age and Tenure
7.9yrs
Average Tenure
50yo
Average Age
Experienced Board: CCM's board of directors are considered experienced (7.9 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Management Team
Yaw Kong Yap (55yo)
CFO & President
- Tenure: 0.6yrs
Jianyu Yang (48yo)
Chairman & CEO
- Tenure: 11.8yrs
Xun Liu
Financial Controller
- Tenure: 7.9yrs
Matthew Callister (49yo)
Chief Medical Officer
- Tenure: 0.6yrs
Xiao Fu (52yo)
Chief Operating Officer
- Tenure: 0.6yrs
Board Members
Denny Lee (52yo)
Independent Director
- Tenure: 9.8yrs
Zheng Cheng (56yo)
Director
- Tenure: 11.8yrs
Jianyu Yang (48yo)
Chairman & CEO
- Tenure: 11.8yrs
Shang Yan Chuang (37yo)
Director
- Tenure: 2.3yrs
Weibo Yin (88yo)
Independent Director
- Tenure: 7.9yrs
Liping Zhang (47yo)
Independent Director
- Tenure: 2.1yrs
Company Information
Concord Medical Services Holdings Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Concord Medical Services Holdings Limited
- Ticker: CCM
- Exchange: NYSE
- Founded: 2007
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$102.190m
- Shares outstanding: 43.39m
- Website: https://www.concordmedical.com
Number of Employees
Location
- Concord Medical Services Holdings Limited
- Tower A, Global Trade Center
- 18th Floor
- Beijing
- 100013
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CCM | NYSE (New York Stock Exchange) | Yes | ADS EACH 1 REPR 3 ORD SHS (USD0.0001) | US | USD | Dec 2009 |
| C2CA | DB (Deutsche Boerse AG) | Yes | ADS EACH 1 REPR 3 ORD SHS (USD0.0001) | DE | EUR | Dec 2009 |
Biography
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. The company operates in Network and ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/18 00:01 |
| End of Day Share Price | 2019/10/17 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.